Videos / New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Non-Hormonal Options for Menopausal Symptoms

Holter Monitoring in GP – Cases and Practical Tips

Management of Constipation in Children

Inhaler Devices – Common User Errors

expert
Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland